This site is intended for health professionals only

Home / News / RPS and others call for stronger PPE guidance

RPS and others call for stronger PPE guidance


By Awil Mohamoud

19 Feb 2021

Almost 20 healthcare bodies, including the Royal Pharmaceutical Society (RPS), have written to Prime Minister Boris Johnson calling for stronger PPE guidance amid emerging scientific evidence around the transmission of Covid-19. 

The letter, dated 18 February, said measures to reduce airborne spread in healthcare settings have been ‘inadequate’, and called for an ‘urgent intervention’ to protect health workers, including with better masks and ventilation.

This comes as researchers recently found that coughing generated at least 10 times more infectious aerosol emissions than breathing or speaking – and recommended FFP3 masks in Covid hot zones and similar locations to reflect this

The Department of Health and Social Care has told the Pharmacist’s sister title, Pulse, that the Government will ‘continue to closely monitor new and emerging evidence’ on airborne transmission, and will update the advice ‘where necessary’.

The letter, signed by healthcare leaders, including GPs, said: ‘Current policies continue to emphasise the importance of fomite, droplet and direct spread but do not properly address airborne transmission.’

It added: ‘There is now no scientific doubt that Covid-19 spreads via the airborne route. There is also direct empirical evidence that the virus is readily transmitted in health care settings beyond formally-classified aerosol generating procedures (AGPs).’

It urged the Mr Johnson to take the lead to address the ‘inconsistencies and gaps in guidance’ by increasing the level of protection for healthcare workers.

The letter said at least 930 health and social care workers have lost their lives due to Covid-19, and that many more are suffering long-term effects. 

Sandra Gidley, RPS president, said: ‘Pharmacists and pharmacy teams are on the frontline of the Covid-19 pandemic and have shown enormous dedication to supporting patient care under the most challenging circumstances.

‘As our understanding of Covid-19 variants evolves, it’s vital that guidance and support keeps pace so that all health and care workers receive the protection they need.’

A version of this story first appeared on our sister title, Pulse.


Want news like this straight to your inbox?


Latest News

Naloxone
Naloxone should be available in every community pharmacy in Scotland, says RPS
The Royal Pharmaceutical Society (RPS) in Scotland is calling for naloxone, which blocks the effects...
co-codamol
4,000 packs of co-codamol recalled over incorrect dosage concerns
Over 4,000 packs of co-codamol 30/500 effervescent tablets made by the manufacturer Zentiva Pharma UK...
Blood pressure medication
Covid causes new fluoxetine shortage
The antidepressant, fluoxetine (Olena) 20mg dispersible sugar free tablets, will be out of stock until...